These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 621816)
41. The natural history of patients less than 40 years old with bladder tumors. Kurz KR; Pitts WR; Vaughan ED J Urol; 1987 Mar; 137(3):395-7. PubMed ID: 3820365 [TBL] [Abstract][Full Text] [Related]
42. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence. Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584 [TBL] [Abstract][Full Text] [Related]
43. Carcinoma in a bladder diverticulum: presentation and treatment outcome. Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771 [TBL] [Abstract][Full Text] [Related]
45. Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum. Malcolm AW; Perencevich NP; Olson RM; Hanley JA; Chaffey JT; Wilson RE Surg Gynecol Obstet; 1981 Feb; 152(2):131-6. PubMed ID: 7209752 [TBL] [Abstract][Full Text] [Related]
46. Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females. Kochakarn W; Chaimuangraj S; Leenanupunth C; Muangman V J Med Assoc Thai; 2001 Jun; 84(6):889-92. PubMed ID: 11556471 [TBL] [Abstract][Full Text] [Related]
47. Radical cystectomy for carcinoma of the bladder: 16 years of experience. Richie JP; Skinner DG; Kaufman JJ J Urol; 1975 Feb; 113(2):186-9. PubMed ID: 1113413 [TBL] [Abstract][Full Text] [Related]
49. Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer. Li CE; Chien CS; Chuang YC; Chang YI; Tang HP; Kang CH Int Urol Nephrol; 2016 Jun; 48(6):993-9. PubMed ID: 26995008 [TBL] [Abstract][Full Text] [Related]
50. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection. Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724 [TBL] [Abstract][Full Text] [Related]
51. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837 [TBL] [Abstract][Full Text] [Related]
52. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
53. Partial cystectomy in the treatment of bladder cancer. Evans RA; Texter JH J Urol; 1975 Sep; 114(3):391-3. PubMed ID: 1142521 [TBL] [Abstract][Full Text] [Related]
54. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? Thrasher JB; Frazier HA; Robertson JE; Paulson DF J Urol; 1994 Aug; 152(2 Pt 1):393-6. PubMed ID: 8015078 [TBL] [Abstract][Full Text] [Related]